- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hemostasis in New Zealand
Total 934 results
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
PfizerCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States
-
NYU Langone HealthMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Siyang LengCompleted
-
Ajai ChariNovartis PharmaceuticalsCompletedMultiple MyelomaUnited States
-
Hearn Jay ChoBristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenCompletedMultiple MyelomaUnited States
-
Regeneron PharmaceuticalsRecruiting
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Not yet recruiting
-
PfizerCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research...TerminatedPhase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell TransplantMultiple MyelomaUnited States
-
Ajai ChariTerminatedMultiple MyelomaUnited States
-
Columbia UniversityCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneTerminated
-
NYU Langone HealthCelgeneTerminatedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States
-
Vivolux ABTheradexTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterTrillium Therapeutics Inc.Active, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
University of Michigan Rogel Cancer CenterCelgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene; Onyx/AmgenActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterColumbia University; Montefiore Medical Center; Weill Medical College of Cornell... and other collaboratorsCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Gilead SciencesTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedMultiple MyelomaUnited States
-
NYU Langone HealthCephalonTerminated
-
University of RochesterRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityTerminatedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterBeyondSpring Pharmaceuticals Inc.Active, not recruiting
-
Innate PharmaCompletedMultiple MyelomaUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Hackensack Meridian HealthJanssen, LPTerminatedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCCompletedMultiple MyelomaUnited States